Korro Bio (KRRO) shares rose 13.5% in recent Thursday trading after Piper Sandler upgraded the stock to overweight from neutral and raised its price target to $30 per share from $11.
HC Wainwright and Chardan also upgraded the stock to buy from neutral. HC Wainwright had a price target of $20 per share, while Chardan boosted its price target to $15 per share from $7.
Trading volume stood at about 970,500 shares compared with a daily average of 533,201.
Price: 13.31, Change: +1.62, Percent Change: +13.82
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments